Cytosorbents Corp reports results for the quarter ended December 31 - Earnings Summary

• Cytosorbents Corp CTSO.OQ reported a quarterly adjusted loss of 14 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -13 cents. The mean expectation of three analysts for the quarter was for a loss of 6 cents per share. Wall Street expected results to range from -7 cents to -6 cents per share.

• Revenue rose 5.6% to $9.15 million from a year ago; analysts expected $10.10 million.

• Cytosorbents Corp's reported EPS for the quarter was a loss of 14 cents​.

• The company reported a quarterly loss of $7.57 million.

• Cytosorbents Corp shares had risen by 9.9% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 5% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for Cytosorbents Corp is $7.00

This summary was machine generated from LSEG data March 31 at 09:53 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)